Health Related Quality of Life and Associated Factors of Inflammatory Bowel Disease Outpatient Unit in Dr. Cipto Mangunkusumo Hospital

(1) Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(2) Division of Gastroenterology, Pancreatobiliary and Gastrointestinal Endoscopy, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(3) Division of Gastroenterology, Pancreatobiliary and Gastrointestinal Endoscopy, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(4) Division of Psychosomatic and Palliative Care, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(5) Division of Psychosomatic and Palliative Care, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(6) Division of Gastroenterology, Pancreatobiliary and Gastrointestinal Endoscopy, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(7) Division of Gastroenterology, Pancreatobiliary and Gastrointestinal Endoscopy, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(8) Division of Geriatric, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(9) Division of Geriatric, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(10) Division of Endocrinology and Metabolism, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(11) Division of Endocrinology and Metabolism, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(12) Division of Cardiology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(13) Division of Cardiology, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(14) Division of Tropical Infection, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
(15) Division of Tropical Infection, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

Abstract
Background: Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is an inflammatory digestive tract condition with unknown causes. Its unpredictable symptoms affect quality of life. In Indonesia, the quality of life of IBD patients remains unreported. Factors such as advanced age, long disease duration, active disease, corticosteroid use, comorbidities, unemployment, and poor sleep quality may reduce quality of life. This study aims to assess the quality of life profile of IBD patients and its associated factors.
Methods: This cross-sectional study collected data from October to November 2024 through interviews at the outpatient unit of Dr. Cipto Mangunkusumo Hospital (RSCM). Quality of life was measured using the Inflammatory Bowel Disease Questionnaire 9 (IBDQ-9), and sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI). Both tools were validated in Indonesian. Eligible participants met inclusion and exclusion criteria. Bivariate and multivariate logistic regression analyses identified factors associated with quality of life.
Results: Among 201 participants, 95% reported a good quality of life. Multivariate analysis identified active disease (PR 4.072 [1.133–14.633], p = 0.031) and combination therapy (PR 12.803 [1.423–115.147], p = 0.023) as factors associated with poor quality of life. Age, disease duration, comorbidities, employment status, and sleep quality showed no significant associations.
Conclusion: Most IBD patients (95%) in the RSCM outpatient unit reported a good quality of life. Active disease and combination therapy were linked to poorer quality of life.
Keywords
References
Djojoningrat D. Inflammatory bowel disease: alur diagnosis dan pengobatannya di Indonesia. In: Sudoyo AW, Setiati S, Alwi I, Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam. Jilid I. Edisi VI. Jakarta: Interna Publishing; 2014. p. 591.
Rowe WA, Lichtenstein GR. Inflammatory bowel disease. In: Anand BS, editor. Pennsylvania: eMedicine; 2020.
Friedman S, Blumberg RS. Inflammatory bowel disease. In: Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018. p. 2258–76.
Picco M. Inflammatory bowel disease. In: Talley NJ, editor. Clinical Gastroenterology: A Practical Problem-Based Approach. 3rd ed. Australia: Elsevier; 2011. p. 190–204.
Siew NG. Emerging trends of inflammatory bowel disease in Asia. Beijing: Millennium Medical Publishing; 2016.
Abdullah M, Syam AF, Simadibrata M, Gunawan J, Makmun D, Rani AA. New insights in the pathomechanisms of inflammatory bowel disease. J Dig Dis. 2013;14:455–62.
Makmun D, Fauzi A, Maulahela H, Pribadi RR, et al. Konsensus nasional penatalaksanaan inflammatory bowel disease (IBD) di Indonesia (Revisi 2019). Jakarta: Interna Publishing; 2019. p. 1–52.
Koma AEM. The multifactorial etiopathogenesis interplay of inflammatory bowel disease: an overview. Gastrointest Disord. 2019;1:75–105.
Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019 Jan;17(1):107–18. doi: 10.5217/ir.2018.00099.
Habibi F, Habibi ME, Gharavinia A, Mahdavi SB, Akbarpour MJ, Baghaei A, et al. Quality of life in inflammatory bowel disease patients: a cross-sectional study. J Res Med Sci. 2017 Sep 26;22:104. doi: 10.4103/jrms.JRMS_975_16.
Velonias G, Conway G, Andrews E, Garber JJ, Khalili H, Yajnik V, et al. Older age and health-related quality of life in inflammatory bowel diseases. Inflamm Bowel Dis. 2017 Feb;23(2):283–8. doi: 10.1097/MIB.0000000000001008.
Liu C, Zhang J, Chen M, An P, Xiang J, Yu R, et al. Gender differences in psychological symptoms and quality of life in patients with inflammatory bowel disease in China: a multicenter study. J Clin Med. 2023 Feb 23;12(5):1791. doi: 10.3390/jcm12051791.
Severs MJJ, Mangen ME, van der Valk HH, Fidder G, Dijkstra M, van der Have M, et al; COIN Study Group; Dutch Initiative on Crohn and Colitis. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohns Colitis. 2017 Mar;11(3):342–52.
Huppertz-Hauss G, Lie Høivik M, Langholz E, Odes S, Småstuen M, Stockbrugger R, et al. Health-related quality of life in inflammatory bowel disease in a European-wide population-based cohort 10 years after diagnosis. Inflamm Bowel Dis. 2015;21(2):337–44.
Esa DF, Simadibrata M, Shatri H, Martin RC. Kesahihan dan keandalan Inflammatory Bowel Disease Questionnaire-9 (IBDQ-9) versi Bahasa Indonesia untuk menilai kualitas hidup pasien dengan penyakit radang usus [tesis]. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2023.
Zhou Y, Ren W, Irvine EJ, Yang D. Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China. J Clin Nurs. 2010;19:79–88. doi: 10.1111/j.1365-2702.2009.03020.x.
Stroie T, Preda C, Meianu C, Croitoru A, Gheorghe L, Gheorghe C, et al. Health-related quality of life in patients with inflammatory bowel disease in clinical remission: what should we look for? Medicina (Kaunas). 2022 Mar 27;58(4):486. doi: 10.3390/medicina58040486. PMID: 35454325; PMCID: PMC9028218.
Zheng K, Zhang S, Wang C, Zhao W, Shen H. Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitis. PLoS One. 2015;10(4):e0124211. doi: 10.1371/journal.pone.0124211.
García-Alanís M, Quiroz-Casian L, Castañeda-González H, Arguelles-Castro P, Toapanta-Yanchapaxi L, Chiquete-Anaya E, et al. Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease. Gastroenterol Hepatol. 2021 Mar 1;44(3):206–13.
Swaminathan D, Fan GM, Borichevsky TC, Mules EC, Hirschfeld E, Frampton CM, et al. The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Aliment Pharmacol Ther. 2022;56(4):664–74. doi: 10.1111/apt.17057.
Panaccione R, Ghosh S, Middleton S, Márquez JR, Scott BB, Flint L, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014 Feb;146(2):392–400.e3. doi: 10.1053/j.gastro.2013.10.052. PMID: 24512909.
Fu H, Kaminga AC, Peng Y, et al. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms. BMC Gastroenterol. 2020;20:11. doi: 10.1186/s12876-020-1166-y.
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—Part II. Inflamm Bowel Dis. 2018;24(5):966–76.
De Boer AG, Evertsz FB, Stokkers PC, Bockting CL, Sanderman R, Hommes DW, et al. Employment status, difficulties at work and quality of life in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol. 2016;28(10):1130–6.
Scott J, Flowers O, Rowse G. Do specific types of sleep disturbances represent risk factors for poorer health-related quality of life in inflammatory bowel disease? A longitudinal cohort study. Br J Health Psychol. 2021;26(1):90–108.
Szmyd B, Rogut M, Białasiewicz P, Gabryelska A. The impact of glucocorticoids and statins on sleep quality. Sleep Med Rev. 2021 Feb;55:101380. doi: 10.1016/j.smrv.2020.101380. Epub 2020 Sep 9. PMID: 33010620.
Zhang JZ, Song XZ, Song XN, Shen YL, Tang H, Li H. Prevalence and risk factors of sleep disorders in inflammatory bowel disease: a cross-sectional study. Int J Colorectal Dis. 2024 Sep 13;39(1):140. doi: 10.1007/s00384-024-04712-w. PMID: 39266810; PMCID: PMC11393029.
Article Metrics
Abstract View

DOI: 10.24871/2622025107-113
Refbacks
- There are currently no refbacks.